Takeda Pharmaceutical Co. Ltd. has reshaped its image as a growing global company, which has led to success in recruiting top talent and negotiating agreements with new partners, according to president of research and development Andy Plump. But despite writing a new growth story, the Japanese big pharma still is struggling to sell its plan to investors.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?